$TFFP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TFF Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TFF Pharmaceuticals, Inc.. Get notifications about new insider transactions in TFF Pharmaceuticals, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | TFFP | TFF Pharmaceutical ... | Lung Therapeutics, Inc. | 10% Owner | Sell | S | 14.00 | 715,000 | 10,010,000 | 2,235,000 | 3 M to 2.2 M (-24.24 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Option Exercise | M | 5.00 | 5,250 | 26,250 | 102,423 | |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Option Exercise | M | 2.50 | 14,756 | 36,890 | 107,673 | |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Sell | S | 16.85 | 20,006 | 337,101 | 15,722 | 35.7 K to 15.7 K (-56.00 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Buy | M | 5.00 | 5,250 | 26,250 | 35,728 | 30.5 K to 35.7 K (+17.23 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Buy | M | 2.50 | 14,756 | 36,890 | 30,478 | 15.7 K to 30.5 K (+93.86 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | M | 2.50 | 50,000 | 125,000 | 944,227 | |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Sell | S | 17.04 | 50,000 | 852,000 | 10,000 | 60 K to 10 K (-83.33 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Buy | M | 2.50 | 50,000 | 125,000 | 60,000 | 10 K to 60 K (+500.00 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Option Exercise | M | 2.50 | 5,000 | 12,500 | 277,883 | |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Sell | S | 17.05 | 5,000 | 85,250 | 1,000 | 6 K to 1,000 (-83.33 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Buy | M | 2.50 | 5,000 | 12,500 | 6,000 | 1,000 to 6 K (+500.00 %) |
| Feb 18 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | M | 2.50 | 40,000 | 100,000 | 994,227 | |
| Feb 18 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Sell | S | 16.82 | 40,000 | 672,800 | 10,000 | 50 K to 10 K (-80.00 %) |
| Feb 18 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Buy | M | 2.50 | 40,000 | 100,000 | 50,000 | 10 K to 50 K (+400.00 %) |
| Feb 18 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Option Exercise | M | 2.50 | 5,000 | 12,500 | 282,883 | |
| Feb 18 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Sell | S | 16.82 | 5,000 | 84,100 | 1,000 | 6 K to 1,000 (-83.33 %) |
| Feb 18 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Buy | M | 2.50 | 5,000 | 12,500 | 6,000 | 1,000 to 6 K (+500.00 %) |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Option Exercise | M | 2.50 | 12,600 | 31,500 | 152,019 | |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Option Exercise | M | 2.50 | 55,100 | 137,750 | 164,619 | |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Sell | S | 20.20 | 12,600 | 254,520 | 15,980 | 28.6 K to 16 K (-44.09 %) |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Buy | M | 2.50 | 12,600 | 31,500 | 28,580 | 16 K to 28.6 K (+78.85 %) |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Sell | S | 19.56 | 55,100 | 1,077,756 | 15,980 | 71.1 K to 16 K (-77.52 %) |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Buy | M | 2.50 | 55,100 | 137,750 | 71,080 | 16 K to 71.1 K (+344.81 %) |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | M | 2.50 | 40,000 | 100,000 | 1,034,227 | |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Sell | S | 17.51 | 40,000 | 700,400 | 10,000 | 50 K to 10 K (-80.00 %) |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Buy | M | 2.50 | 40,000 | 100,000 | 50,000 | 10 K to 50 K (+400.00 %) |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Sell | S | 17.00 | 3,000 | 51,000 | 7,000 | 10 K to 7 K (-30.00 %) |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Option Exercise | M | 2.50 | 5,000 | 12,500 | 287,883 | |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Sell | S | 17.50 | 5,000 | 87,500 | 1,000 | 6 K to 1,000 (-83.33 %) |
| Jan 20 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Buy | M | 2.50 | 5,000 | 12,500 | 6,000 | 1,000 to 6 K (+500.00 %) |
| Dec 29 2020 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | M | 2.50 | 30,000 | 75,000 | 1,074,227 | |
| Dec 29 2020 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Sell | S | 15.33 | 30,000 | 459,900 | 10,000 | 40 K to 10 K (-75.00 %) |
| Dec 29 2020 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Buy | M | 2.50 | 30,000 | 75,000 | 40,000 | 10 K to 40 K (+300.00 %) |
| Dec 29 2020 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Option Exercise | M | 2.50 | 10,000 | 25,000 | 292,883 | |
| Dec 29 2020 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Sell | S | 15.24 | 10,000 | 152,400 | 1,000 | 11 K to 1,000 (-90.91 %) |
| Dec 29 2020 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Buy | M | 2.50 | 10,000 | 25,000 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
| Dec 15 2020 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Option Exercise | M | 2.50 | 22,794 | 56,985 | 219,719 | |
| Dec 15 2020 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Sell | S | 14.58 | 22,794 | 332,337 | 15,980 | 38.8 K to 16 K (-58.79 %) |
| Dec 15 2020 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Buy | M | 2.50 | 22,794 | 56,985 | 38,774 | 16 K to 38.8 K (+142.64 %) |
| Dec 09 2020 | TFFP | TFF Pharmaceutical ... | WINDSOR JAMES BRIAN | Chief Science Offic ... | Option Exercise | M | 2.50 | 25,000 | 62,500 | 134,429 | |
| Dec 09 2020 | TFFP | TFF Pharmaceutical ... | WINDSOR JAMES BRIAN | Chief Science Offic ... | Sell | S | 15.80 | 25,000 | 395,000 | 5,000 | 30 K to 5 K (-83.33 %) |
| Dec 09 2020 | TFFP | TFF Pharmaceutical ... | WINDSOR JAMES BRIAN | Chief Science Offic ... | Buy | M | 2.50 | 25,000 | 62,500 | 30,000 | 5 K to 30 K (+500.00 %) |
| Dec 08 2020 | TFFP | TFF Pharmaceutical ... | Lung Therapeutics, Inc. | 10% Owner | Sell | S | 13.86 | 250,000 | 3,465,000 | 2,950,000 | 3.2 M to 3 M (-7.81 %) |
| Dec 08 2020 | TFFP | TFF Pharmaceutical ... | Lung Therapeutics, Inc. | 10% Owner | Sell | S | 13.86 | 300,000 | 4,158,000 | 3,200,000 | 3.5 M to 3.2 M (-8.57 %) |
| Dec 08 2020 | TFFP | TFF Pharmaceutical ... | Lung Therapeutics, Inc. | 10% Owner | Sell | S | 13.85 | 500,000 | 6,925,000 | 3,500,000 | 4 M to 3.5 M (-12.50 %) |
| Nov 24 2020 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Buy | P | 15.13 | 5,000 | 75,656 | 100,000 | 95 K to 100 K (+5.26 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | Fairbairn Malcolm | Director | Sell | S | 15.97 | 11,669 | 186,307 | 0 | 11.7 K to 0 (-100.00 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | Fairbairn Malcolm | Director | Sell | S | 15.93 | 63,331 | 1,008,926 | 11,669 | 75 K to 11.7 K (-84.44 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | THURMAN RANDY H | Director | Option Exercise | M | 2.50 | 34,504 | 86,260 | 124,925 | |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | THURMAN RANDY H | Director | Sell | S | 17.17 | 5,000 | 85,865 | 0 | 5 K to 0 (-100.00 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | THURMAN RANDY H | Director | Sell | S | 15.91 | 34,504 | 548,890 | 5,000 | 39.5 K to 5 K (-87.34 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | THURMAN RANDY H | Director | Buy | M | 2.50 | 34,504 | 86,260 | 39,504 | 5 K to 39.5 K (+690.08 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Option Exercise | M | 2.50 | 15,722 | 39,305 | 122,429 | |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Option Exercise | M | 2.50 | 21,278 | 53,195 | 138,151 | |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Sell | S | 15.76 | 15,722 | 247,732 | 0 | 15.7 K to 0 (-100.00 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Buy | M | 2.50 | 15,722 | 39,305 | 15,722 | 0 to 15.7 K |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Sell | S | 15.14 | 21,278 | 322,106 | 0 | 21.3 K to 0 (-100.00 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Buy | M | 2.50 | 21,278 | 53,195 | 21,278 | 0 to 21.3 K |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary, and ... | Option Exercise | M | 2.50 | 15,000 | 37,500 | 302,883 | |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary, and ... | Sell | S | 15.12 | 15,000 | 226,755 | 1,000 | 16 K to 1,000 (-93.75 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary, and ... | Buy | M | 2.50 | 15,000 | 37,500 | 16,000 | 1,000 to 16 K (+1,500.00 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | M | 2.50 | 108,830 | 272,075 | 1,104,227 | |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Sell | S | 15.00 | 108,830 | 1,631,906 | 10,000 | 118.8 K to 10 K (-91.58 %) |
| Nov 13 2020 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Buy | M | 2.50 | 108,830 | 272,075 | 118,830 | 10 K to 118.8 K (+1,088.30 %) |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Option Exercise | A | 13.65 | 20,000 | 273,000 | 159,429 | |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Option Exercise | A | 13.65 | 30,300 | 413,595 | 242,512 | |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Option Exercise | A | 5.00 | 25,838 | 129,190 | 212,212 | |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | THURMAN RANDY H | Director | Option Exercise | A | 13.65 | 20,000 | 273,000 | 159,429 | |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | Fairbairn Malcolm | Director | Option Exercise | A | 13.65 | 13,200 | 180,180 | 105,455 | |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary, and ... | Option Exercise | A | 13.65 | 40,000 | 546,000 | 317,883 | |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | Weisman Harlan F | Director | Option Exercise | A | 13.65 | 20,000 | 273,000 | 159,429 | |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | A | 13.65 | 152,000 | 2,074,800 | 1,213,057 | |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | A | 5.00 | 89,952 | 449,760 | 1,061,057 | |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | WINDSOR JAMES BRIAN | Chief Science Offic ... | Option Exercise | A | 13.65 | 20,000 | 273,000 | 159,429 | |
| Aug 26 2020 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Option Exercise | A | 13.65 | 20,000 | 273,000 | 159,429 | |
| May 26 2020 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Buy | P | 5.08 | 20,000 | 101,600 | 95,000 | 75 K to 95 K (+26.67 %) |
| Apr 17 2020 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Buy | P | 4.72 | 5,581 | 26,342 | 75,000 | 69.4 K to 75 K (+8.04 %) |
| Apr 06 2020 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Buy | P | 4.24 | 6,252 | 26,508 | 69,419 | 63.2 K to 69.4 K (+9.90 %) |
| Apr 06 2020 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Buy | P | 3.97 | 16,748 | 66,490 | 63,167 | 46.4 K to 63.2 K (+36.08 %) |
| Apr 06 2020 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Buy | P | 3.75 | 500 | 1,875 | 46,419 | 45.9 K to 46.4 K (+1.09 %) |
| Feb 19 2020 | TFFP | TFF Pharmaceutical ... | Fairbairn Malcolm | Director | Option Exercise | A | 5.06 | 92,255 | 466,810 | 92,255 | |
| Dec 26 2019 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary, and ... | Option Exercise | A | 5.16 | 50,000 | 258,000 | 277,883 | |
| Dec 03 2019 | TFFP | TFF Pharmaceutical ... | WINDSOR JAMES BRIAN | Chief Science Offic ... | Option Exercise | A | 5.00 | 3,623 | 18,115 | 139,429 | |
| Dec 03 2019 | TFFP | TFF Pharmaceutical ... | Weisman Harlan F | Director | Option Exercise | A | 5.00 | 3,623 | 18,115 | 139,429 | |
| Dec 03 2019 | TFFP | TFF Pharmaceutical ... | THURMAN RANDY H | Director | Option Exercise | A | 5.00 | 3,623 | 18,115 | 139,429 | |
| Dec 03 2019 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Option Exercise | A | 5.00 | 3,623 | 18,115 | 139,429 | |
| Dec 03 2019 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Option Exercise | A | 5.00 | 2,351 | 11,755 | 186,374 | |
| Dec 03 2019 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | A | 5.00 | 25,214 | 126,070 | 971,105 | |
| Dec 03 2019 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Option Exercise | A | 5.00 | 3,623 | 18,115 | 139,429 | |
| Dec 03 2019 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary, and ... | Option Exercise | A | 5.00 | 5,920 | 29,600 | 227,883 | |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Option Exercise | A | 5.00 | 43,794 | 218,970 | 135,806 | |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | WINDSOR JAMES BRIAN | Chief Science Offic ... | Option Exercise | A | 5.00 | 43,794 | 218,970 | 135,806 | |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | WINDSOR JAMES BRIAN | Chief Science Offic ... | Buy | P | 5.00 | 5,000 | 25,000 | 5,000 | 0 to 5 K |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | Weisman Harlan F | Director | Option Exercise | A | 5.00 | 43,794 | 218,970 | 135,806 | |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | Weisman Harlan F | Director | Buy | P | 5.00 | 5,000 | 25,000 | 5,000 | 0 to 5 K |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | THURMAN RANDY H | Director | Option Exercise | A | 5.00 | 43,794 | 218,970 | 135,806 | |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | THURMAN RANDY H | Director | Buy | P | 5.00 | 5,000 | 25,000 | 5,000 | 0 to 5 K |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Option Exercise | C | 0.00 | 10,980 | 0 | 184,023 | |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Buy | C | 0.00 | 10,980 | 0 | 15,980 | 5 K to 16 K (+219.60 %) |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | MILLS ROBERT S | Director | Buy | P | 5.00 | 5,000 | 25,000 | 5,000 | 0 to 5 K |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | A | 5.00 | 332,868 | 1,664,340 | 945,891 | |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Buy | P | 5.00 | 10,000 | 50,000 | 10,000 | 0 to 10 K |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Option Exercise | C | 0.00 | 43,919 | 0 | 135,806 | |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Option Exercise | A | 5.00 | 43,794 | 218,970 | 179,693 | |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Buy | C | 0.00 | 43,919 | 0 | 45,919 | 2 K to 45.9 K (+2,195.95 %) |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | Fletcher Aaron G.L. | Director | Buy | P | 5.00 | 2,000 | 10,000 | 2,000 | 0 to 2 K |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary, and ... | Option Exercise | A | 5.00 | 71,963 | 359,815 | 221,963 | |
| Oct 29 2019 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary, and ... | Buy | P | 5.00 | 1,000 | 5,000 | 1,000 | 0 to 1,000 |
Page: 1